Intellia Therapeutics, Inc. - Common Stock (NTLA)
CUSIP: 45826J105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 118,202,207
- Total 13F shares
- 90,118,237
- Share change
- -1,133,245
- Total reported value
- $2,016,932,908
- Put/Call ratio
- 133%
- Price per share
- $22.38
- Number of holders
- 286
- Value change
- -$33,057,144
- Number of buys
- 153
- Number of sells
- 124
Quarterly Holders Quick Answers
What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45826J105:
Top shareholders of NTLA - Intellia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
|
Company |
9.3%
|
10,989,282
|
$302,315,161 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.7%
|
9,109,268
|
$250,595,969 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.7%
|
9,093,712
|
$250,168,017 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
4,597,822
|
$126,486,083 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.6%
|
4,210,784
|
$115,838,668 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.5%
|
4,162,129
|
$114,500,168 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
2.9%
|
3,399,318
|
$93,515,238 | — | 31 Mar 2024 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
2.9%
|
3,399,318
|
$93,379,265 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.2%
|
2,644,851
|
$72,759,891 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
1.9%
|
2,206,342
|
$60,696,455 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
2,044,257
|
$56,245,771 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.6%
|
1,929,700
|
$53,086,047 | — | 31 Mar 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
1.6%
|
1,875,000
|
$51,581,250 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.4%
|
1,625,051
|
$44,707,000 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.3%
|
1,571,524
|
$43,232,625 | — | 31 Mar 2024 | |
| Rokos Capital Management LLP |
13F
|
Company |
1.2%
|
1,463,630
|
$40,205,916 | — | 31 Mar 2024 | |
| Contrarius Investment Management Ltd |
13F
|
Company |
1.1%
|
1,350,531
|
$37,153,000 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1%
|
1,225,696
|
$33,718,889 | — | 31 Mar 2024 | |
| Chevy Chase Trust Holdings, LLC |
13F
|
Company |
0.91%
|
1,074,610
|
$29,562,521 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.9%
|
1,067,460
|
$29,365,822 | — | 31 Mar 2024 | |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. |
13F
|
Company |
0.87%
|
1,030,621
|
$28,352,384 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.75%
|
890,784
|
$24,505,468 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.74%
|
871,295
|
$23,969,325 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.68%
|
805,103
|
$22,148,384 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.67%
|
795,514
|
$21,884,590 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.62%
|
728,295
|
$20,035,396 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.56%
|
659,317
|
$18,137,811 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.53%
|
626,423
|
$17,232,896 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.52%
|
614,568
|
$16,906,766 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.52%
|
614,151
|
$16,895,294 | — | 31 Mar 2024 | |
| Discovery Value Fund |
13F
|
Company |
0.48%
|
561,561
|
$15,448,543 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.46%
|
543,107
|
$14,940,873 | — | 31 Mar 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.37%
|
432,598
|
$11,900,771 | — | 31 Mar 2024 | |
| Vestmark Advisory Solutions, Inc. |
13F
|
Company |
0.36%
|
420,397
|
$11,565,115 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.32%
|
383,868
|
$10,560,209 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.32%
|
379,638
|
$10,443,841 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
362,005
|
$9,958,771 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.29%
|
342,966
|
$9,434,995 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.28%
|
335,408
|
$9,227,074 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
331,586
|
$9,121,931 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.27%
|
323,561
|
$8,901,163 | — | 31 Mar 2024 | |
| CAPITAL ADVISORS INC/OK |
13F
|
Company |
0.25%
|
300,653
|
$8,270,964 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.18%
|
217,394
|
$7,727,578 | — | 31 Mar 2024 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.24%
|
279,693
|
$7,694,354 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.23%
|
266,964
|
$7,344,180 | — | 31 Mar 2024 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.22%
|
255,716
|
$7,034,747 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.22%
|
255,000
|
$7,015,050 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.21%
|
247,300
|
$6,803,223 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.21%
|
245,776
|
$6,761,298 | — | 31 Mar 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.2%
|
238,000
|
$6,547,380 | — | 31 Mar 2024 |
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q2 2024
As of 30 Jun 2024,
Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by
286 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,118,237 shares.
The largest 10 holders included
ARK Investment Management LLC, BlackRock Inc., VANGUARD GROUP INC, Deep Track Capital, LP, STATE STREET CORP, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., MORGAN STANLEY, FEDERATED HERMES, INC., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
288
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
279
Q2 2024 holders
286
Holder diff
7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.